Syntimmune

Alexion Pharmaceuticals acquires Boston-based biotech company
New Haven Register
Sun, 11/4/18 - 02:31 pm
Alexion Pharmaceuticals
M&A
Syntimmune
Alexion to buy biotech firm Syntimmune for up to $1.2 billion
Reuters
Wed, 09/26/18 - 07:24 pm
Alexion
Syntimmune
M&A